JY
NUVB icon

Jeff Yass’s Nuvation Bio NUVB Stock Holding History

Jeff Yass’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$654K Sell
115,100
-114,000
-50% -$557K ﹤0.01% 9281
2026
Q1 		$983K Sell
229,100
-75,000
-25% -$418K ﹤0.01% 7932
2025
Q4 		$2.72M Buy
304,100
+55,700
+22% +$345K ﹤0.01% 5051
2025
Q3 		$919K Buy
248,400
+134,600
+118% +$367K ﹤0.01% 7552
2025
Q2 		$222K Buy
+113,800
New +$237K ﹤0.01% 10998
2022
Q4 		– Sell
-10,100
Closed -$23K – 13284
2022
Q3 		$23K Buy
+10,100
New +$28.8K ﹤0.01% 12554
2022
Q1 		– Sell
-14,600
Closed -$124K – 13674
2021
Q4 		$124K Sell
14,600
-7,000
-32% -$64.3K ﹤0.01% 11982
2021
Q3 		$215K Sell
21,600
-62,700
-74% -$568K ﹤0.01% 11334
2021
Q2 		$785K Buy
+84,300
New +$961K ﹤0.01% 8430

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Jeff Yass's NUVB Position: Q2 2026 in Review

Jeff Yass increased its Nuvation Bio (NUVB) stake by 537% in Q2 2026, buying an estimated $3.77M and bringing the position to 914,779 shares worth $5.2M. The position accounts for ﹤0.01% of the portfolio, ranked #4539.

Jeff Yass first reported a position in NUVB in Q1 2021 and has held it in 20 quarters since. 242 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Jeff Yass held 914,779 shares of Nuvation Bio worth $5.2M as of Q2 2026.
  • Jeff Yass bought 771,166 Nuvation Bio shares in Q2 2026, an estimated $3.77M.
  • Nuvation Bio made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #4539 holding.
  • Jeff Yass first reported a position in Nuvation Bio in Q1 2021 and has held it in 20 quarters since.
  • 242 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.